if you stop taking glp 1 do you gain weight Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Loss Ozempic, Wegovy, Mounjaro: How to

Current studies support that liraglutide can prevent and treat worsening PAH symptoms [82]

Lifestyle approaches nutrition, weight-bearing exercises, and healthy habits are essential for long-term bone health

Final Thoughts Staying hydrated on weight loss injections like Mounjaro or Wegovy is not just about drinking water

Heres what they shared about their maintenance approaches and outcomes: Demographics of Interview Group 32 women, 15 men Ages 31-67 (median 44) Starting BMI 32-51 (median 38) Weight lost: 22-104 pounds (median 48 pounds) Medications: 28 tirzepatide, 12 semaglutide, 7 retatrutide Current Status After 18-36 Months Maintenance Strategies and Outcomes Key Findings from Patient Interviews Chronic treatment group (31 patients): 27 successfully reduced to maintenance doses (50-75% of peak dose) Annual cost ranges $2,400-14,000 depending on source and dose 23 have insurance coverage or use research peptide suppliers 4 express concern about long-term financial sustainability 29 report improved quality of life despite ongoing treatment Cycling group (8 patients): Average cycle: 4 months on, 5 months off Weight fluctuates 12-22 pounds between cycles All maintain intensive lifestyle practices during off periods 6 find this psychologically preferable to chronic treatment 2 are considering transition to chronic treatment due to regain pattern Discontinuation attempt group (8 patients): Average regain: 65% of lost weight within 18 months All implemented intensive lifestyle protocols 5 have restarted or plan to restart medication 3 accept higher stable weight as compromise Universal report of persistent increased hunger versus on-medication state Most Valuable Patient Insights Sarah, 42, tirzepatide user for 26 months: I tried to stop after losing 55 pounds

Check the medication, membership, lab, shipping, insurance, and savings components together

A 10 mg vial is ideal for the titration phase when weekly doses are small (2-4 mg), because the vial gets used within its optimal potency window